AIM: To assess the distribution of human leukocyte antigen (HLA)-DQ2 and -DQ8 in Iranian celiac disease (CD) patients and compare them to healthy Iranian controls. METHODS: To predict the HLA-DQA1 and -DQB1 genes, we used six previously reported HLA-tagging single nucleotide polymorphism to determine HLA genotypes in 59 Iranian patients with 'biopsy-confirmed' CD and in 151 healthy Iranian individuals. To test the transferability of the method, 50 cases and controls were also typed using a commercial kit that identifies individual carriers of DQ2, DQ7 and DQ8 alleles. RESULTS: In this pilot study 97% of CD cases (n = 57) and 58% of controls (n = 87) were carriers of HLA-DQ2 and/or HLA-DQ8 heterodimers, either in the homozygous or heterozygous state. The HLA-DQ pattern of these 57 CD patients: heterozygous DQ2.2 (n = 14) and homozygous DQ2.2 (n = 1), heterozygous DQ2.5 (n = 33) and homozygous DQ2.5 (n = 8), heterozygous DQ8 (n = 13) and homozygous DQ8 (n = 2). Two CD patients were negative for both DQ2 and DQ8 (3%). CONCLUSION: The prevalence of DQ8 in our CD population was higher than that reported in other populations (25.4%). As reported in other populations, our results underline the primary importance of HLA-DQ alleles in the Iranian population's susceptibility to CD.
AIM: To assess the distribution of human leukocyte antigen (HLA)-DQ2 and -DQ8 in Iranian celiac disease (CD) patients and compare them to healthy Iranian controls. METHODS: To predict the HLA-DQA1 and -DQB1 genes, we used six previously reported HLA-tagging single nucleotide polymorphism to determine HLA genotypes in 59 Iranian patients with 'biopsy-confirmed' CD and in 151 healthy Iranian individuals. To test the transferability of the method, 50 cases and controls were also typed using a commercial kit that identifies individual carriers of DQ2, DQ7 and DQ8 alleles. RESULTS: In this pilot study 97% of CD cases (n = 57) and 58% of controls (n = 87) were carriers of HLA-DQ2 and/or HLA-DQ8 heterodimers, either in the homozygous or heterozygous state. The HLA-DQ pattern of these 57 CD patients: heterozygous DQ2.2 (n = 14) and homozygous DQ2.2 (n = 1), heterozygous DQ2.5 (n = 33) and homozygous DQ2.5 (n = 8), heterozygous DQ8 (n = 13) and homozygous DQ8 (n = 2). Two CD patients were negative for both DQ2 and DQ8 (3%). CONCLUSION: The prevalence of DQ8 in our CD population was higher than that reported in other populations (25.4%). As reported in other populations, our results underline the primary importance of HLA-DQ alleles in the Iranian population's susceptibility to CD.
Entities:
Keywords:
Celiac disease; Human leukocyte antigen typing; Iran; Susceptibility; Validation
Authors: Willemijn Vader; Dariusz Stepniak; Yvonne Kooy; Luisa Mearin; Allan Thompson; Jon J van Rood; Liesbeth Spaenij; Frits Koning Journal: Proc Natl Acad Sci U S A Date: 2003-10-06 Impact factor: 11.205
Authors: Paul Zubillaga; Maria Concepcion Vidales; Itziar Zubillaga; Victor Ormaechea; Nerea García-Urkía; Juan Carlos Vitoria Journal: J Pediatr Gastroenterol Nutr Date: 2002-05 Impact factor: 2.839
Authors: Kati Karell; Andrew S Louka; Simon J Moodie; Henry Ascher; Fabienne Clot; Luigi Greco; Paul J Ciclitira; Ludvig M Sollid; Jukka Partanen Journal: Hum Immunol Date: 2003-04 Impact factor: 2.850
Authors: Robert P Anderson; Margaret J Henry; Roberta Taylor; Emma L Duncan; Patrick Danoy; Marylia J Costa; Kathryn Addison; Jason A Tye-Din; Mark A Kotowicz; Ross E Knight; Wendy Pollock; Geoffrey C Nicholson; Ban-Hock Toh; Matthew A Brown; Julie A Pasco Journal: BMC Med Date: 2013-08-28 Impact factor: 8.775
Authors: Mohammad Rostami-Nejad; Mohammad Javad Ehsani-Ardakani; Hamid Assadzadeh; Bijan Shahbazkhani; Enzo Ierardi; Giuseppe Losurdo; Homayon Zojaji; Amirhoshang Mohammad Alizadeh; Nosratollah Naderi; Amir Sadeghi; Mohammad Reza Zali Journal: Middle East J Dig Dis Date: 2016-04